Researchers studied the effectiveness of five newer anti-seizure medications (ASMs) in treating Lennox-Gastaut syndrome (LGS), a severe form of epilepsy that begins in childhood and is often resistant to treatment.
This study looked at the long-term quality of life for people who survived a severe type of epilepsy called new onset refractory status epilepticus (NORSE), including a specific form known as febrile infection-related epilepsy syndrome (FIRES).
This study looked at how often and when side effects occurred in adult Asian patients with focal-onset seizures while they were treated with brivaracetam (BRV).
This study looked at the blood levels of two substances, cannabidiol (CBD) and tetrahydrocannabinol (THC), in children with epilepsy that does not respond to standard treatments.
Researchers studied a specific type of epilepsy linked to mutations in the KCNT1 gene, which causes potassium channels in the brain to become overly active.
This study focused on late-onset epilepsy (LOE), which occurs in people over the age of 50, and the challenges in diagnosing its causes.
Researchers studied how to analyze data from trials that look at the effects of treatments over time, specifically focusing on a method called Latent Change Models (LCMs).
This study looked at the effects of adding metformin, a medication commonly used for diabetes, to standard anti-seizure treatments in people with active epilepsy.
This study looked at the effects of a medication called mycophenolate mofetil (MMF) on patients with a serious condition known as anti-NMDA receptor encephalitis (NMDARE).